Sign In
Free Newsletter
Rockville bio manufacturing facility sold
BioMed Realty Trust Inc. announced Thursday that it has closed on the sale of a biological manufacturing facility in Rockville for approximately $322.5 million. The property, at 9911 Belward Campus Drive, is 289,900 square feet and 100 percent leased to Human Genome Sciences Inc. The purchaser is a subsidiary of GI Partners, a private equity firm. […]
Judge refuses to delay Glaxo-Human Genome deal
DOVER, Del. — A federal judge in Delaware has refused to issue a restraining order delaying the acquisition of Human Genome Sciences Inc. by GlaxoSmithKline. Two HGS shareholders had argued that the tender offer period should be extended beyond Friday’s deadline because Glaxo’s agreement last week to pay $14.25 a share represented a new deal […]
Report: GSK in deal talks with Human Genome
NEW YORK — GlaxoSmithKline PLC is reportedly talking this weekend with Human Genome Sciences Inc. about its $2.6 billion offer for the Rockville-based biotech company. British drug maker GlaxoSmithKline made its first bid for the biotech company in April and extended its offer of $13 per share until July 20. Human Genome Sciences has dismissed […]
Human Genome Sciences enters talks with potential suitors
Human Genome Sciences Inc. entered into confidentiality agreements with “certain parties” and is providing an opportunity to engage in due diligence reviews, the Rockville-based company said Thursday. Its board of directors unanimously said shareholders should reject an “inadequate” $2.6 billion bid from British pharmaceutical giant GlaxoSmithKline plc. Glaxo said on May 9 it would commenc[...]
Week in review: 4/27/12
Superblock firm gets extension City officials Wednesday have given developers of the $150 million Superblock project on downtown’s West Side until Dec. 31 to line up financing and retail tenants. This is the second extension for the firm, Lexington Square Partners LLC, of New York and Atlanta, which says it’s negotiating with an anchor tenant. […]
